Patents by Inventor Benjamin Ko

Benjamin Ko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12171688
    Abstract: An apparatus includes a body, and anchoring feature, and a guide feature. The body is sized and configured to be positioned on an eye of a patient. The anchoring feature is configured to secure the body to the eye of the patient. The guide feature is configured to guide a cannula into a scleral incision formed in the eye of the patient along a path that is substantially tangential relative to the eye of the patient. The guide feature is sized and configured to allow the cannula to pivot laterally through a range of angular motion at the scleral incision.
    Type: Grant
    Filed: December 15, 2021
    Date of Patent: December 24, 2024
    Assignee: Genentech, Inc.
    Inventors: Thomas E. Meyer, Mark Hedgeland, Benjamin Ko, Thomas Gernetzke, Olivia Enneking, Eric Kennedy, Robert Roth, Michael Auld, Jacob Schubert, Samuel Ridgley
  • Publication number: 20230390111
    Abstract: An apparatus includes a body, and anchoring feature, and a guide feature. The body is sized and configured to be positioned on an eye of a patient. The anchoring feature is configured to secure the body to the eye of the patient. The guide feature is configured to guide a cannula into a scleral incision formed in the eye of the patient along a path that is substantially tangential relative to the eye of the patient. The guide feature is sized and configured to allow the cannula to pivot laterally through a range of angular motion at the scleral incision.
    Type: Application
    Filed: December 15, 2021
    Publication date: December 7, 2023
    Inventors: Thomas E. Meyer, Mark Hedgeland, Benjamin Ko, Thomas Gernetzke, Olivia Enneking, Eric Kennedy, Robert Roth, Michael Auld, Jacob Schubert, Samuel Ridgley
  • Patent number: 5866424
    Abstract: The present invention addresses the need to ensure that clinical tests for urobilinogen in urine are properly working. The invention specifically provides a novel liquid urobilinogen composition which remains stable in liquid form for eighteen months and a method for making the same.
    Type: Grant
    Filed: July 10, 1995
    Date of Patent: February 2, 1999
    Assignee: Bayer Corporation
    Inventor: Benjamin Ko